Skip to content
GenoLensGenoLens

FGF12

Chr 3q28-q29

fibroblast growth factor 12

Aliases:
FHF1
MANE:
ENST00000445105.7

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Early onset or syndromic epilepsy

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Intellectual disability

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Fetal anomalies

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Mitochondrial disorders

Disease associations (Open Targets)

  • genetic developmental and epileptic encephalopathy

    0.65
  • neurodegenerative disease

    0.47
  • Epileptic encephalopathy

    0.47
  • undetermined early-onset epileptic encephalopathy

    0.37
  • Seizure

    0.34
  • cervical carcinoma

    0.33
  • insomnia

    0.29
  • brain injury

    0.28
  • pyogenic granuloma

    0.27
  • atherosclerosis

    0.23

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Fibroblast growth factor 12

Involved in nervous system development and function. Involved in the positive regulation of voltage-gated sodium channel activity. Promotes neuronal excitability by elevating the voltage dependence of neuronal sodium channel SCN8A fast inactivation

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.